http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0247689-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bc08fffeb2983b92f28dba9bc231f91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46e16fd9cf4f5783fbc529a059c07fe3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fecfbb065888ed349719e44feaeb2730
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c82fea9cd3dc48540ebd26d3b952479
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001924a4247a91f605a4a0dddcf4579a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44db2cd28c36b7568b00911857ded0b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_913c1be9b6da8689583aabfe4f926f71
publicationDate 2002-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0247689-A2
titleOfInvention Use of cetirizine or efletirizine for preventing urticaria
abstract The present invention relates to the use of a compound selected from efletirizine, cetirizine or an individual optical isomer of cetirizine or a pharmaceutically acceptable salt of any of these for the preparation of a medicament intended for preventing, or delaying the onset of, an urticaria attack in a patient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101185612-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9180090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314083-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8633194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9119771-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9161902-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005261953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8263581-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8513259-B2
priorityDate 2000-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9928310-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0010544-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449460137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129915741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227876085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136211813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415733015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127488854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830

Total number of triples: 58.